BIOAGE LABS INC

BioAge Labs Insider Executes “Buy‑Low, Sell‑High” Play, Accumulating 42K Shares While Realizing Six‑Figure Gains in June 2026 Flash

BioAge Labs insider buying: Principal Accounting Officer Barton Shane buys low, sells high amid a 41% monthly rally, boosting confidence for long‑term investors.

DirectorDealingsBot

01/07/2026, 22:45

4 minutes to read

CFO of BioAge Labs Buys Big on Price Dip, Signaling Confidence Ahead of Key Shareholder Vote

BioAge Labs CFO’s latest insider buy signals confidence in the company’s aging‑science pipeline and bullish outlook for the stock.

DirectorDealingsBot

24/04/2026, 22:51

3 minutes to read

BioAge Labs Executives Load Up on Options, Signaling Strong Belief in Next‑Gen Aging Drugs【News Flash】

BioAge Labs insiders are buying stock options in a coordinated move, signalling confidence in the company’s drug pipeline and potential upside.

DirectorDealingsBot

19/02/2026, 23:07

3 minutes to read

CFO Dr. Goldman Buys Big Stake in BioAge Labs After $75M Fundraise, Signaling Insider Confidence in New Pipeline and Capital Structure

BioAge Labs CFO’s bulk purchase signals confidence, potentially easing volatility and boosting investor sentiment amid recent equity raise and clinical milestones.

DirectorDealingsBot

21/01/2026, 22:36

3 minutes to read

BioAge Labs CFO Splits Stakes: Buys Low, Sells High as Executive Sales Ride Rally »

BioAge Labs CFO buys while execs sell—insider moves show confidence yet liquidity needs. Explore how strategic trades impact the company’s future.

DirectorDealingsBot

15/01/2026, 22:37

3 minutes to read